Newsletter-21

461 LEGAL DEVELOPMENTS • The Board authorized the merger of Weyerhaeuser Company and Plum Creek Timber Company, Inc. (28.12.2015, 15- 46/765-280) • The Board authorized the acquisition of the cardiovascular equipment sales and the distribution department of Opakim Tıbbi Ürünler Sanayi ve Ticaret A.Ş. by St. Jude Medical Inc. (28.12.2015, 15-46/767-282) • The Board authorized the acquisition of the control over DYO Matbaa Mürekkepleri Sanayi ve Ticaret A.Ş. by Toyo Ink SC Holdings Co., Ltd. (06.01.2016, 16-1/1-1) • The Board authorized the acquisition of Milas Ambalaj ve Sanayi Ticaret A.Ş. by DS Smith Packaging International B.V. from Alfasa Family. (06.01.2016, 16-1/8-3) • The Board authorized the acquisition of the joint control over Laboratoire HRA Pharma SAS and its affiliates by Astorg Asset Management S.a.r.l. and Goldman Sachs Group Inc. (06.01.2016, 16-01/13-6) • The Board authorized the acquisition of the joint control over Bombardier Transportation (Investment) UK Limited by CDP Investissements Inc. (06.01.2016, 16-01/13-6) • The Board authorized the acquisition of the control over To- tal Oil TürkiyeA.Ş. by Demirören HoldingA.Ş. (14.01.2016, 16-02/28-7) • The Board authorized the acquisition of the sole control over RTS Renal Tedavi Hizmetleri San. ve Tic. A.Ş. by Baxter Healthcare S.A., formerly jointly controlled by Eczacıbaşı- Baxter Hastane Ürünleri San. ve Tic. A.Ş. and RTS World- wide Inc. (14.01.2016, 16-02/35-12) • The Board authorized the acquisition of joint control over CVC Strategic Opportunities Platform and Sphinx Invest- ment Pte. Ltd. by RAC Group (Holdings) Limited through the acquisition of a certain ratio of shares in Carlyle Europe Partners III by CVC Strategic Opportunities Platform, and